<?xml version="1.0" encoding="UTF-8"?>
<p>As of early October 2019, over 840 pregnant women in the Ebola outbreak zone of DRC have received the rVSV-ZEBOV vaccine [
 <xref rid="B39-vaccines-08-00038" ref-type="bibr">39</xref>]. At this early phase in the administration of the vaccine to pregnant women and their infants, data regarding maternal, fetal, or neonatal indicators and outcomes are still being collected.
</p>
